F. Ann Millner Sells 3,106 Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) Stock

Merit Medical Systems, Inc. (NASDAQ:MMSI) Director F. Ann Millner sold 3,106 shares of Merit Medical Systems stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $41.01, for a total transaction of $127,377.06. Following the transaction, the director now directly owns 6,750 shares of the company’s stock, valued at $276,817.50. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.

F. Ann Millner also recently made the following trade(s):

  • On Wednesday, June 28th, F. Ann Millner sold 6,744 shares of Merit Medical Systems stock. The shares were sold at an average price of $38.15, for a total transaction of $257,283.60.

Shares of Merit Medical Systems, Inc. (NASDAQ MMSI) traded down 0.24% on Friday, reaching $40.75. 169,830 shares of the company’s stock traded hands. Merit Medical Systems, Inc. has a 12-month low of $20.70 and a 12-month high of $42.60. The stock has a 50-day moving average price of $39.50 and a 200-day moving average price of $33.55. The company has a market cap of $2.04 billion, a PE ratio of 58.05 and a beta of 1.26.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings data on Wednesday, July 26th. The medical instruments supplier reported $0.36 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.29 by $0.07. Merit Medical Systems had a net margin of 4.87% and a return on equity of 9.78%. The firm had revenue of $186.50 million during the quarter, compared to analyst estimates of $181.46 million. During the same period last year, the firm posted $0.26 EPS. Merit Medical Systems’s revenue was up 23.4% on a year-over-year basis. Equities research analysts anticipate that Merit Medical Systems, Inc. will post $1.26 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “F. Ann Millner Sells 3,106 Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) Stock” was reported by BNB Daily and is the sole property of of BNB Daily. If you are viewing this piece of content on another publication, it was illegally stolen and reposted in violation of US & international copyright law. The correct version of this piece of content can be viewed at https://www.baseball-news-blog.com/2017/08/19/f-ann-millner-sells-3106-shares-of-merit-medical-systems-inc-nasdaqmmsi-stock-updated.html.

A number of institutional investors have recently bought and sold shares of MMSI. Russell Investments Group Ltd. acquired a new position in Merit Medical Systems during the fourth quarter worth about $503,000. Norges Bank acquired a new position in Merit Medical Systems during the fourth quarter worth about $7,773,000. Teachers Advisors LLC raised its position in Merit Medical Systems by 0.7% in the fourth quarter. Teachers Advisors LLC now owns 557,413 shares of the medical instruments supplier’s stock worth $14,771,000 after buying an additional 3,839 shares in the last quarter. Macquarie Group Ltd. raised its position in Merit Medical Systems by 7.5% in the fourth quarter. Macquarie Group Ltd. now owns 985,064 shares of the medical instruments supplier’s stock worth $26,104,000 after buying an additional 68,601 shares in the last quarter. Finally, Louisiana State Employees Retirement System raised its position in Merit Medical Systems by 11.7% in the first quarter. Louisiana State Employees Retirement System now owns 20,000 shares of the medical instruments supplier’s stock worth $578,000 after buying an additional 2,100 shares in the last quarter. 91.64% of the stock is owned by institutional investors.

A number of research analysts recently issued reports on the stock. Piper Jaffray Companies reissued a “buy” rating and set a $45.00 price target on shares of Merit Medical Systems in a research report on Friday, July 28th. Bank of America Corporation assumed coverage on shares of Merit Medical Systems in a report on Thursday, July 20th. They issued a “buy” rating and a $44.00 target price for the company. Craig Hallum reaffirmed a “buy” rating and issued a $50.00 target price (up from $42.00) on shares of Merit Medical Systems in a report on Thursday, July 27th. BidaskClub raised shares of Merit Medical Systems from a “buy” rating to a “strong-buy” rating in a report on Tuesday, June 27th. Finally, Sidoti reaffirmed a “buy” rating and issued a $46.00 target price (up from $41.00) on shares of Merit Medical Systems in a report on Wednesday, June 28th. One research analyst has rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the stock. Merit Medical Systems presently has a consensus rating of “Buy” and a consensus target price of $39.74.

About Merit Medical Systems

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Insider Buying and Selling by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply